Bertram Aschenbrenner
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The Controversial Link Between Human Papillomavirus Infection and Esophageal Health: An Exploratory Translational Study.
Journal: Pathogens (Basel, Switzerland)
Published: December 18, 2025
Targeting P2RY2 reprograms tumor immunity and inhibits tumor growth in non-small cell lung cancer.
Journal: Cancer letters
Published: November 11, 2025
Cancer-associated fibroblast subtypes modulate the tumor-immune microenvironment and are associated with skin cancer malignancy.
Journal: Nature communications
Published: April 10, 2023
Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis.
Journal: Cells
Published: December 12, 2022
Simvastatin is effective in killing the radioresistant breast carcinoma cells.
Journal: Radiology and oncology
Published: March 10, 2021
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
Journal: Theranostics
Published: January 25, 2021
Molecular heterogeneity in breast carcinoma cells with increased invasive capacities.
Journal: Radiology and oncology
Published: January 10, 2020
Bioavailability of phthalate and DINCH® plasticizers, after oral administration of dust to piglets.
Journal: Toxicology letters
Published: February 22, 2019
The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 07, 2018
RAF1/BRAF dimerization integrates the signal from RAS to ERK and ROKα.
Journal: Science signaling
Published: March 09, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026